Bafna Pharmaceuticals Ltd.
BAFNAPH Share PricePharmaceuticals & Drugs
₹145.19
-3 (-2%)
As on December 4, 2025
Exchange Scrips: BSE532989NSEBAFNAPHISININE878I01022
Market Cap ₹ 343 Cr
P/E Ratio -15.83
Dividend Yield N/A
Performance
Market performance
Open145.19
High145.19
Volumes126
Prev145.19
Low145.19
As on2025-12-04
Historical performance
1 Year High202.06
3 Year High202.06
5 Year High233.55
1 Year Low69
3 Year Low69
5 Year Low69
Fundamentals
Company Valuation
Market Cap (₹Cr)
343
Face Value (₹)
10
P/E Ratio
-15.83
Dividend Yield
N/A
Investment Returns
1 Year
77.6%
3 Years
46.4%
5 Years
-1.4%
10 Years
236.1%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 150.02 | Bearish |
| 10-DMA | 155.04 | Bearish |
| 20-DMA | 167.22 | Bearish |
| 50-DMA | 159.85 | Bearish |
| 100-DMA | 129.72 | Bullish |
| 200-DMA | 103.31 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 7 | 7 | 7 | 7 | 7 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 7 | 7 | 7 | 7 | 7 |
| Public Investors | 7565 | 7276 | 7135 | 7207 | 7288 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -15.83.
- 3Y Stock Price CAGR of the stock is 12.3.
- The stock has a beta of 0.2.
- In the last financial year, the company had an EBITDA of ₹15 Million.
- The company generated revenue of ₹425 Million in the previous financial year.
Bafna Pharmaceuticals Ltd.
145.19-3 (-2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1803602.5
No. of Shares: 12422 (Approx)
Performance:80.4%
P/L: ₹803602.5
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
